Toshihiro Mita Selected Research

Therapeutics

1/2022	Circulation of an Artemisinin-Resistant Malaria Lineage in a Traveler Returning from East Africa to France.
4/2021	Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
6/2016	Morpholino antisense oligo inhibits trans-splicing of pre-inositol 1,4,5-trisphosphate receptor mRNA of Trypanosoma cruzi and suppresses parasite growth and infectivity.
1/2016	Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites.
10/2013	Travellers as sentinels: Assaying the worldwide distribution of polymorphisms associated with artemisinin combination therapy resistance in Plasmodium falciparum using malaria cases imported into Scotland.
1/2011	Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies.
6/2010	High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiro Mita Research Topics

Disease

32	Malaria 05/2024 - 06/2010
7	Falciparum Malaria (Plasmodium falciparum Malaria) 04/2024 - 04/2003
4	Infections 01/2022 - 06/2016
2	Communicable Diseases (Infectious Diseases) 06/2022 - 06/2016
1	Parasitemia 01/2023
1	Measles 06/2022
1	Rubella (German Measles) 06/2022
1	Dysbiosis 02/2022
1	Ulcerative Colitis 02/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Amebiasis (Amoebiasis) 01/2022
1	Hepatitis 01/2022
1	Amebic Liver Abscess 01/2022
1	Neoplasms (Cancer) 01/2022
1	Parasitic Diseases (Parasitic Disease) 01/2022
1	Chagas Disease (American Trypanosomiasis) 12/2016
1	Hypoxia (Hypoxemia) 04/2016
1	Vivax Malaria 06/2011

Drug/Important Bio-Agent (IBA)

15	artemisinin (artemisinine)IBA 04/2024 - 06/2010
5	VaccinesIBA 06/2015 - 06/2011
4	Chloroquine (Aralen)FDA LinkGeneric 02/2020 - 04/2003
3	Pyrimethamine (Daraprim)FDA Link 05/2024 - 06/2010
3	Malaria VaccinesIBA 01/2023 - 02/2012
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2012
2	pyrimethamine drug combination fanasil (Fansidar)FDA Link 05/2024 - 11/2006
2	Antimalarials (Antimalarial Agents)IBA 04/2024 - 06/2022
2	Immunoglobulin G (IgG)IBA 06/2022 - 01/2022
2	ArtesunateIBA 01/2022 - 01/2021
2	Lumefantrine FDA Link 02/2020 - 11/2018
2	2,3,6-trichloroindophenolIBA 12/2016 - 06/2016
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2016 - 08/2014
2	AntigensIBA 06/2015 - 02/2013
1	Histidine (L-Histidine)FDA Link 04/2022
1	AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Sulfadoxine (Sulformethoxine)FDA Link 10/2021
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 04/2021
1	piperaquineIBA 01/2021
1	Messenger RNA (mRNA)IBA 06/2016
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 06/2016
1	MyoglobinIBA 04/2016
1	MetmyoglobinIBA 04/2016
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	NAD (NADH)IBA 04/2016
1	Adenylosuccinate LyaseIBA 06/2015
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 06/2015
1	Genetic Markers (Genetic Marker)IBA 06/2015
1	Merozoite Surface Protein 1 (MSA1)IBA 06/2015
1	N 30IBA 06/2015
1	Folic Acid AntagonistsIBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2011

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2010
1	Chemoprevention 05/2024
1	Aftercare (After-Treatment) 01/2023
1	Fecal Microbiota Transplantation 02/2022
1	Donor Selection 02/2022
1	Diagnostic Equipment 01/2020